Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

PRAMOSONE

HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE

Standard Dose
0.5%;1%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview PRAMOSONE is listed in Drugs@FDA under application 083778 (ANDA).

Marketing status: Prescription Active ingredient HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE Form and strength CREAM;TOPICAL - 0.5%;1% Sponsor LEGACY PHARMA Submission history Latest submission status date: 1992-08-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview PRAMOSONE is listed in Drugs@FDA under application 083778 (ANDA). Marketing status: Prescription Active ingredient HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE Form and strength CREAM;TOPICAL - 0.5%;1% Sponsor LEGACY PHARMA Submission history Latest submission status date: 1992-08-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.
PRAMOSONE (HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline